Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Barata

Showing results (151-160 of 203) with videos related to

Pageof 21
Sort By:
European Urology Oncology|June 12, 2024
Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination TherapyNeal D Shore, Michael S Broder, Pedro C Barata, et al.
The Oncologist|August 19, 2025
Advanced Urothelial Carcinoma Treated with Enfortumab Vedotin and Pembrolizumab: A Path to Cure?Albert Jang, Nikita Tripathi, Sree M Lanka, et al.
Clinical Genitourinary Cancer|March 27, 2018
Feasibility of Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Patients With Diminished Renal FunctionVadim S Koshkin, Pedro C Barata, Lisa A Rybicki, et al.
Journal for Immunotherapy of Cancer|January 31, 2018
Clinical activity of nivolumab in patients with non-clear cell renal cell carcinomaVadim S Koshkin, Pedro C Barata, Tian Zhang, et al.
The Prostate|March 24, 2023
Clinical and molecular determinants of PSA response to bipolar androgen therapy in prostate cancerSydney A Caputo, Madeline Hawkins, Ellen B Jaeger, et al.
BJU International|July 17, 2024
Pathological concordance rate and outcomes by subtype in advanced papillary renal cell carcinomaAbhishek Tripathi, Catherine M Tangen, Melissa Plets, et al.
Research Square|August 23, 2023
Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaborationTanya Dorff, Zeynep Zengin, Nicholas Henderson, et al.
JCO Precision Oncology|July 19, 2023
Longitudinal Monitoring of Circulating Tumor DNA to Assess the Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Genitourinary MalignanciesAlbert Jang, Sree M Lanka, Ellen B Jaeger, et al.
Urology Practice|October 10, 2025
Persistent Sex Disparities in Bladder Cancer Diagnosis: An Analysis of National Trends From 2012 to 2021Edward Z Zhang, Jack C Millot, Adithya Balasubramanian, et al.
European Urology Oncology|August 15, 2019
Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot StudyPetros Grivas, Aly-Khan A Lalani, Gregory R Pond, et al.
Pageof 21

Showing results (151-160 of 203) with videos related to

Sort By:
Pageof 21
European Urology Oncology|June 12, 2024
Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination TherapyNeal D Shore, Michael S Broder, Pedro C Barata, et al.
The Oncologist|August 19, 2025
Advanced Urothelial Carcinoma Treated with Enfortumab Vedotin and Pembrolizumab: A Path to Cure?Albert Jang, Nikita Tripathi, Sree M Lanka, et al.
Clinical Genitourinary Cancer|March 27, 2018
Feasibility of Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Patients With Diminished Renal FunctionVadim S Koshkin, Pedro C Barata, Lisa A Rybicki, et al.
Journal for Immunotherapy of Cancer|January 31, 2018
Clinical activity of nivolumab in patients with non-clear cell renal cell carcinomaVadim S Koshkin, Pedro C Barata, Tian Zhang, et al.
The Prostate|March 24, 2023
Clinical and molecular determinants of PSA response to bipolar androgen therapy in prostate cancerSydney A Caputo, Madeline Hawkins, Ellen B Jaeger, et al.
BJU International|July 17, 2024
Pathological concordance rate and outcomes by subtype in advanced papillary renal cell carcinomaAbhishek Tripathi, Catherine M Tangen, Melissa Plets, et al.
Research Square|August 23, 2023
Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaborationTanya Dorff, Zeynep Zengin, Nicholas Henderson, et al.
JCO Precision Oncology|July 19, 2023
Longitudinal Monitoring of Circulating Tumor DNA to Assess the Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Genitourinary MalignanciesAlbert Jang, Sree M Lanka, Ellen B Jaeger, et al.
Urology Practice|October 10, 2025
Persistent Sex Disparities in Bladder Cancer Diagnosis: An Analysis of National Trends From 2012 to 2021Edward Z Zhang, Jack C Millot, Adithya Balasubramanian, et al.
European Urology Oncology|August 15, 2019
Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot StudyPetros Grivas, Aly-Khan A Lalani, Gregory R Pond, et al.
Pageof 21